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To date, urethral stricture disease in men, though relatively common, represents an often poorly managed condition. Therefore,
this article is dedicated to encompassing the currently existing data upon anatomy, etiology, symptoms, diagnosis, and treatment
of the disease, based on more than 40 years of experience at a tertiary referral center and a PubMed literature review enclosing
publications until September 2018.
1. Introduction
Urethral stricture disease can develop throughout the entire
length of the male urethra and can be caused by a large
variety of etiologies. Also, urethral strictures give rise to
a wide range of symptoms and warrant a specific diag-
nostic work-up before proceeding to any treatment modal-
ity.
The management of urethral stricture disease has a
profound history and may embody one of the oldest doc-
umented urological entities known to mankind. In the
second half of the 20th century, urologists have attempted
to find solutions to treat both simple and complex ure-
thral strictures and, over the last few decades, research has
mainly been focused on refining the existing procedures to
mitigate the negative postoperative consequences. However,
despite the substantial scientific progress on this subject,
a numerous amount of studies has revealed the insuffi-
cient knowledge about urethral stricture surgery among
urologists and has shown that patients with urethral stric-
tures are generally offered an inadequate treatment option
[1–3].
Against this background, the article outlines the existing
data about anatomy, etiology, symptoms, diagnosis, and
treatment of male urethral stricture disease.
2. Anatomy
The terminology describing male urethral anatomy is often
used incorrectly and thus needs clarification. In fact, the male
urethra consists of the following segments (from bladder
neck to meatus urethrae): the posterior urethra, containing
the prostatic urethra and the membranous urethra, and
the anterior or spongious urethra (embedded in corpus
spongiosum), containing the bulbar urethra (between the
membranous urethra and the penoscrotal angle) and the
penile urethra (between the penoscrotal angle and themeatus
urethrae) (Figure 1). Diseases of the prostatic urethra are
beyond the scope of this article as they largely overlap with
specific prostate diseases.
3. Etiology
The etiology of urethral stricture disease mainly involves the
following: idiopathic, iatrogenic, external trauma, infection,
and lichen sclerosus. In 2013, a comparative analysis showed
that urethral strictures in India are proportionally more
caused by an external trauma and less by an iatrogenic cause,
when compared to the USA and Italy [4]. Meanwhile, in
the Western World, the most important stricture etiology
is iatrogenic [4–6] and developing countries primarily face
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Figure 1: Anatomy of the male urethra. 1 = bulbar urethra (urethra runs dorsally through corpus spongiosum); 2 = penile urethra (urethra runs
centrally through corpus spongiosum). A = penile urethra; B = bulbar urethra; C = membranous urethra; D = prostatic urethra; E = bladder neck.
infectious strictures after venereal infections or after a non-
specific urethritis [7]. As regards lichen sclerosus, a skin
condition with an important predilection for the anogenital
region, its urethral involvement is a well-known aspect of
the disease and potentially gives rise to urethral strictures
at the penile or bulbar site [8, 9]. Furthermore, it must be
underlined that a substantial amount of stricture etiologies
remains unknown, even after thorough evaluation of the
patient’s history.
3.1. Iatrogenic Stricture Etiology. Themedical world is respon-
sible for a substantial amount of urethral strictures [5].
Every transurethral intervention (e.g., catheter insertion,
introduction of surgical instruments, etc.) can damage the
urethral mucosa and lead to subsequent stricture formation,
even if performed adequately [5]. Therefore, all medical
practitioners should keep this in mind and carefully consider
their indications before proceeding to any transurethral
manipulation. Failed hypospadias repair represents another
important iatrogenic cause of strictures, especially in younger
patients [5]. In a relatively older patient population, local
prostate cancer treatments, mainly involving radical prosta-
tectomy or radiation therapy, are an upcoming etiology
and bring along strictures that are very challenging to treat
[5]. Less frequently, strictures are due to ischemia of the
corpus spongiosum which may occur after hypothermia or
extracorporeal circulation, for instance, during cardiac or
neurosurgery [5]. In these cases, strictures typically involve
the complete anterior urethra because this entire segment
strongly relies on the spongious blood supply.
3.2. External Trauma. External trauma leading to a pelvic
fracture specifically threatens the membranous part of the
male urethra either by a shear injury resulting from the
movement of the pelvic bones or by a laceration injury
caused by bony fragments cutting into the urethra. These
phenomena may result in a partial or total rupture of the
urethra. The associated hematoma formation then further
separates both urethral ends and causes such a disruption
defect in between.
Straddle injuries or a trauma directly impacting the
perineum may damage the bulbar urethra as this part of the
urethra gets crushed between the area of impact and the pubic
bone. Generally, these injuries lead to stricture formation at
the site of urethral damage and are usually accompanied by an
important perineal hematoma due to an associated rupture in
the surrounding spongious tissue.
In case of severe penile fractures, the rupture of the cav-
ernous bodies can be associated with a rupture of the penile
urethra which may lead to subsequent stricture formation.
4. Symptoms and Diagnosis
4.1. Patient History. Patients with a urethral stricture mostly
complain about obstructive voiding symptoms. The most
apparent symptom is weakening of the urinary stream.
However, it is important to understand that all degrees of
obstructive voiding can be present, ranging from a perfectly
normal urinary stream to urinary retention. In case of
a discrete urethral stricture and/or a slowly progressive
onset of symptoms, the patient can indeed report a total
absence of obstructive voiding symptoms as the detrusor
muscle may compensate the lower urinary tract obstruction
by hypertrophy. Other obstructive voiding symptoms may
involve hesitancy, intermittency, straining, post-void drib-
bling, incomplete emptying of the bladder, and spraying
(especially in meatal strictures). Apart from these, develop-
ment of an overactive bladder is frequent as well and brings
along complaints of urgency and frequency.
Other complaints such as hematuria or pollakisuria are
also possible, although they are likely to be the result of
a stricture related complication such as urinary stones,
urethritis, or an infection of the prostate, epididymis, or
testicle.
The presence of a urethral stricture should always be
suspected in case of repetitive infections of the prostate,
epididymis, or testicle.
Next to symptom assessment, history taking should focus
on stricture etiology, previous interventions, relevantmedical
history and comorbidities.
4.2. Physical Examination. During physical examination, the
clinician should palpate the urethra to identify fibrotic tissue
and look for skin changes (e.g., lichen sclerosus), the presence
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of cellulitis, fistulas, or abscesses, the presence and quality of
foreskin to potentially use in later urethral reconstruction and
the presence of scars from prior surgery. These surgical scars
may reveal important information about the type of prior
reconstruction which is sometimes unknown to the patient.
Ideally, the examination of the patient also includes
a digital rectal examination (benign prostatic hyperplasia;
prostatitis) and an evaluation of the external genitals which
might reveal (the consequences of) an epididymitis or an
orchitis.
Be that as it may, imaging studies remain essential to
evaluate the entire male urethra as only part of it can be
evaluated by physical examination.
4.3. Technical Investigations
4.3.1. Uroflowmetry. The maximal urinary flow rate (Qmax)
of an adultmanwith a healthy lower urinary tract is estimated
to be >15 mL/s [10]. A Qmax of <15 mL/s is considered
suspicious for lower urinary tract obstruction and requires
further diagnostic evaluation. Apart from Qmax, it is also
important to interpret the shape of the flow curve as in
patients with a urethral stricture, uroflowmetry may typically
reveal a curve with a plateau-shape at the level of the Qmax
[11–13].
It must be underlined that uroflowmetry studies with
a voided volume < 150 mL can lead to a less valuable
interpretation [12].
4.3.2. Urethroscopy. Urethroscopy is a fast and relatively
easy way to diagnose a urethral stricture. This investigation
provides information about the location and the remaining
caliber of the narrowed urethra (to pass or not to pass with
the cystoscope). If the stricture is too narrow to allow passage
of the cystoscope, no further information about the proximal
urethra can be obtained with this diagnostic modality. In
these cases it can be helpful to introduce a smaller caliber
ureteroscope (4.5 or 6 Fr) which is able to pass through
the strictured area and which thus provides further proxi-
mal information [14]. Apart from that, urethroscopy is also
unable to provide any information about the surrounding
spongiofibrosis. Given these drawbacks, urethroscopy alone
is often considered insufficient for a thorough diagnostic
work-up and additional imaging studies are mostly war-
ranted.
4.3.3. Urethrography. A retrograde urethrography (RUG), in
which contrast is injected through the urethral meatus, is
capable of visualizing the entire urethra (except in cases with
a total obliteration of the urethral lumen) up to the sphincter
and even up to the bladder if patients can relax the sphincter
enough to allow passage of contrast through the prostatic
urethra and bladder neck (Figure 2). However, a RUG alone
often results in insufficient distension of the urethra proximal
to the stricture which may lead to incomplete information
about the proximal stricture extent and the condition of the
more proximal urethra. In this case, an additional voiding
cysto-urethrography (VCUG) after filling the bladder with
contrast (either after RUG or by instillation through a
Figure 2: Retrograde urethrography. Retrograde urethrography
shows an isolated, short, bulbar urethral stricture.
suprapubic catheter) may solve this problem and address the
need for additional information.
The combination of both RUG and VCUG provides
a comprehensive image of the entire urethra and reveals
valuable information about the number of strictures, stricture
length, stricture location, and the remaining caliber of the
narrowed urethra. Nonetheless, RUG and VCUG studies
require careful interpretation and several drawbacks must
be kept in mind. A prestenotic dilation, for instance, can
mask the presence of a urethral stricture or interfere with the
observed stricture length, especially in the bulbar urethra. In
these cases, an additional image in profile view can be very
useful. Furthermore, estimated stricture length, particularly
at the bulbar site, should always be interpreted carefully
as this result poorly correlates with the intraoperatively
measured stricture length [15]. This can be explained by
the fact that a 3-dimensional situation is projected on a 2-
dimensional image and by the fact that the observed stricture
length importantly depends on the patient’s positioning and
the provided penile traction during the investigation [15].
RUG and VCUG are further limited by the fact that—similar
to urethroscopy—none of these studies provide any informa-
tion about the surrounding spongiofibrosis.
4.3.4. Urethral Ultrasound. A urethral ultrasound may be
useful in the diagnostic work-up of urethral strictures, partic-
ularly because it measures stricture length more adequately
and because it reveals information about the surrounding
spongiofibrosis [15]. During this investigation, a linear 7,5
MHz probe is placed sagitally against the region of interest:
ventral penis for penile strictures, perineal for bulbar stric-
tures.The urethra is then visualized as a hypoechogenic band
with an 8 to 10mmdiameter (after instillation of a physiologic
solution through a Foley catheter at the level of the meatus)
and urethral strictures are represented as thick, irregular, and
hyperechogenic zones in and around the depicted urethra
(Figure 3).
Despite the aforementioned assets of urethral ultrasound,
this imaging study is vastly underused in clinical practice
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Figure 3: Ultrasound of the bulbar urethra. Ultrasound shows an
irregular, hyperechogenic zone in the bulbar urethra, representing a
bulbar urethral stricture.
and urethrography remains the routine diagnostic modality,
principally because its rapid information is sufficient for the
reconstructive urologist. Furthermore, as a urethral ultra-
sound takes longer to perform, there is a prolonged period
of retrograde injection of a physiologic solution which is
uncomfortable for the patient when awake.
4.3.5. Magnetic Resonance Imaging (MRI) and Computed
Tomography (CT) Scan. MRI is a very useful tool in case of
tumor related urethral stricture disease. This imaging study
can adequately demonstrate the extent of the disease in the
surrounding tissues, for instance, into the cavernous bodies,
which is of utmost importance for the subsequent surgical
procedure. Further routine use in clinical practice is rather
debatable. Nonetheless, Oh et al. advocate for MRI in case of
complex trauma leading to a completely obliterated posterior
urethra [16] and, more recently, Joshi et al. described a novel
MRI protocol which leads to a reliable measurement of the
urethral gap after pelvic fracture related urethral injuries
[17]. This novel MRI technique could be very useful to plan
and guide subsequent urethral reconstruction in these often
complex cases [17].
A CT voiding urethrography can provide useful informa-
tion in case of stricture related fistulas [18].
5. Treatment
5.1. Dilations. Urethral dilation represents one of the old-
est urological procedures known to mankind. Throughout
history, urologists have invented all sorts of instruments
to progressively dilate urethral strictures up to a normal
caliber. However, since the development of direct vision
internal urethrotomy (DVIU), urethral dilation as a primary
treatment for urethral stricture disease has decreased and
research has started focusing on repetitive (auto)dilations as
a strategy to prevent or delay stricture recurrence after DVIU
(cf. infra) [19, 20].
As the mechanism of urethral dilation implies rupturing
the urethralmucosa at the least scarred region of the stricture,
it allows subsequent urine diffusion in the created defect and
peri-urethral tissues which further nourishes the formation
of scar tissue. Hence, a high stricture recurrence rate can be
expected, either in the short or in the long term. Accordingly,
durable success rates after urethral dilation for a primary,
short urethral stricture lie between 50 and 60% but decrease
to about 20% for strictures longer than 2.0 cm [21, 22].
Nonetheless, these results need to be put in perspective as
DVIU can also cause urinary extravasation into the peri-
urethral tissues and since Steenkamp et al. described no sta-
tistically significant difference in surgical outcome between
DVIU and urethral dilation [21].
Potential risks that are associated with single or repetitive
(auto)dilations include urethral hemorrhage, urinary tract
infection, and sepsis. Furthermore, it is advised not to dilate
the urethra in case of a present urinary tract infection.
5.2. Endoscopic Treatment
5.2.1. Direct Vision Internal Urethrotomy (DVIU). DVIU rep-
resents the basis of endoscopically treating urethral strictures
and is inspired by a French idea, born in the 19th century
(Civiale, 1817;Maisonneuve, 1848).This treatment principally
differs from urethral dilation as it involves an intervention
which is guided by the direct vision of the surgeon. During
this procedure, a longitudinal incision is made over the
entire stricture length into healthy urethral tissue, after which
the gap between the wound edges is expected to be re-
epithelialized.
Today, many urologists feel comfortable treating urethral
strictures with endoscopic urethrotomy. Most likely, this
popularity is mainly a result of its short learning curve, its
relatively fast and simple character, and its paucity of major
complications, rather than its intrinsic surgical outcome.
Moreover, in many urology practices, a thorough knowledge
of and/or experience with open urethral reconstruction are/is
lacking [23].
(1) Indications. The sole indication for DVIU is a primary,
isolated, short (<1.5 cm), bulbar urethral stricture. This
recommendation is based upon several negative prognostic
factors impeding success rates of DVIU: number of previous
urethrotomies (and stricture-free interval hereafter), stricture
length, number of strictures, stricture location, and the
amount of surrounding spongiofibrosis [24, 25].
(2) Results. DVIU for primary urethral strictures <1.5 cm
entails the best surgical outcome, with success rates ranging
up to 80% in case of strictures <1 cm [26]. When performing
DVIU for longer strictures, success rates drop to about 20%
[26]. Moreover, Steenkamp et al. have shown that every
additional centimeter to be treated with DVIU brings along
an extra risk factor (RR: 1.22) for stricture recurrence [21].
(3) Therapeutic Options to Prevent or Delay Stricture Recur-
rence after Urethrotomy
Repetitive (Auto)Dilation. Repetitive (auto)dilation is fre-
quently administered as an adjuvant therapy after DVIU to
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prevent or delay stricture recurrence. This strategy has been
evaluated by several retrospective series which have shown a
limited benefit over DVIU only and these findings have been
corroborated by a recent systematic review andmeta-analysis
[27–30].These studies, however, provide no data about which
specific patient groups might benefit more or less from these
adjuvant dilations and it has been described that repetitive
(auto)dilations are associated with a poor quality of life
[31].
Injection or Instillation with Corticosteroids. Post-urethrot-
omy injection or instillation with corticosteroids has been
evaluated by two randomized [32, 33] and two nonrandom-
ized [34, 35] series, three of which have shown a clear benefit
over DVIU only in strictures <2 cm [32, 34, 35]. However, all
of these reports are based on a poor-quality study design and
thus no clear conclusions can be drawn about the true value
of corticosteroids in this setting.
Injection with Low-Dose Mitomycin C (MMC). Low-dose
MMC (0.1 mg in 2 mL, 5%) injections in the freshly incised
urethral stricture have been described with beneficial results
in an initial small randomized, controlled trial (n=20) [36].
The rationale behind this strategy lies within the antifibrotic
and anticollagen properties of the MMC substance. More
recent studies, involving a large randomized, controlled
trial [37] and a descriptive study in 37 patients [38], have
confirmed the benefit of adding these injections over DVIU
only.
Nevertheless, the use of post-urethrotomy MMC injec-
tions has not exactly found its way into routine clinical
practice. The experienced serious adverse events following
extravasation of MMC after intravesical instillations, even
though these concentrations of MMC are 20 times higher,
might be an explanation for this. Furthermore, this trend
may be further encouraged by the presence of all valuable
alternatives, as mentioned above.
5.2.2. Metallic Endoluminal Stents. Metallic endoluminal
stents are endoscopically inserted after incision of the ure-
thral stricture and are manufactured to maintain a sufficient
caliber at the level of the diseased urethra. These stents
may be particularly interesting in short urethral strictures
as they allow re-epithelization from both extremities. In
more extensive stricture disease, however, the formation of
granulation tissue may overgrow the meshes of the inserted
stent and thus lead to a partial or complete obliteration of the
stent’s endolumen.
These endoluminal stents were enthusiastically intro-
duced in the 1990s, especially for short, recurrent bulbar stric-
tures as they offered promising short-term success rates [39].
However, in the long-term, devastating problems occurred
in patients after endoluminal stent implantation including
restenosis due to overgrowth, stent migration, encrustation,
and infection [39]. Thereafter, endoluminal stents rapidly
decreased in popularity and several reconstructive tech-
niques were advocated for urethroplasty after endoluminal
stent failure [39].
5.2.3. Laser Evaporation of the Stricture. The laser technique
is capable of evaporating the entire urethral stricture, but
it destroys the epithelium of the urethra at the same time.
Considering this, holmium laser urethrotomy is specifically
indicated for short urethral strictures, because, in these
cases, re-epithelization may be expected even sooner than
in classic urethrotomy. Moreover, there is limited evidence
that, for these strictures, the recurrence rates within 1 year
of follow-up are significantly lower after laser urethrotomy,
when compared to cold-knife incision [40]. In case of longer
urethral strictures, less favorable results are to be expected
from this treatment modality, particularly when the urethral
epitheliumhas beendisintegrated over the entire length of the
treated stricture. However, these auspicious results should be
put in perspective as they are supported by a limited amount
of studies, with small sample size, short follow-up and poor
description of the study design and methods [40].
5.3. Open Reconstructive Treatment. Urethroplasty, the open
reconstructive treatment for urethral strictures, is associ-
ated with significantly better long-term success rates than
dilation or any endoscopic treatment option [26]. Over
time, a tremendous amount of surgical techniques has been
described and gradually refined, providing a very rich arma-
mentarium for the reconstructive urologist. The exact choice
of technique for a particular patient with a particular case of
urethral stricture disease will depend on numerous factors,
at least including the following: previous urethral treatments,
number of strictures, stricture length, stricture location,
stricture etiology, comorbidities and the quality of the corpus
spongiosum, the surrounding tissues, and potential graft
sites. Hence, a thorough diagnostic work-up is indispensable
and of utmost importance when selecting the most adequate
treatment option.
5.3.1. Timing of Surgery. Urethroplasty should be timed
adequately and needs to take place after full maturation
of the stricture. Following this logic, the authors believe
that postponing urethral reconstruction until 3 months after
the latest transurethral manipulation is the ideal approach,
although there is no true evidence to support this specific
statement. The rationale behind our timing is that the
introduction of even a small caliber instrument may rupture
the strictured area, causing a significant problem in the
intra-operative determination of the distal extent of the
stricture as a transurethral catheter or Beniqué might fluently
pass through the dilated, but diseased urethra. This in turn
could lead to an insufficient urethroplasty procedure, leaving
fibrotic tissue, and thus stricture disease, behind.
Considering this, urinary diversion will need to be
guaranteed by placing a suprapubic catheter in case of acute
urinary retention.
5.3.2. Preoperative Work-Up. The key-point in preoperative
work-up is to assure that the patient’s urine is sterile during
urethroplasty as a urinary tract infection can complicate the
postoperative course and might contribute to urethroplasty
failure. Therefore, it is advised to perform a urinalysis with
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Figure 4: Exposure of the bulbar urethra. The bulbar urethra is
exposed using 4 stay sutures and a Lone Star retractor.
urine culture and antibiogram one week preoperatively and
to start with appropriate antibiotics 24 hours before surgery.
This is especially important in patients with a suprapu-
bic catheter, in whom the risk of contaminated urine is
substantially higher. In case of a sterile urine portion, a
single dose of cefazoline or a quinolone is administered at
the start of the operation. In these cases, it is unnecessary
to routinely perpetuate the antibiotic treatment regimen
after any urethroplasty since this would only endorse the
increasing problem of resistant microorganisms.
5.3.3. Urethral Access. For a long period of time, the authors
have been using amidline perineal skin incision to access the
bulbar and posterior urethra. This incision gives an excellent
exposure with a minimal risk of wound dehiscence after
closure and it has the advantage to be less painful than
an inverted-U or 𝜆 incision [41]. After the skin incision,
the subcutaneous fat tissue is further dissected until the
level of the bulbospongiosus muscle, which is then incised
longitudinally on the midline and separated from the corpus
spongiosum. Further exposure can be obtained by fixating the
muscle to the perineal skinwith 4 stay sutures and by applying
a self-retaining retractor with multiple stay hooks (Figure 4).
To access the penile urethra, a circumferential skin
incision about 0.5 cm below the glans is an excellent approach
(Figure 5). This incision will provide an excellent, well vas-
cularized coverage of the reconstructed area and minimizes
the risk of postoperative fistulation. After this skin incision,
the penis can be degloved along Buck’s fascia, following the
virtually avascular plane in between, which results in an easy
exposure of the entire penile urethra [42, 43].
An alternative approach to access the penile urethra was
described by Kulkarni et al. and involves invagination of
the penis through a perineal skin incision, thus accessing
the entire penile urethra without the need for a penile skin
incision [44]. This approach offers a perfect coverage of the
penile site of reconstruction and allows total anterior urethral
reconstruction through one perineal incision.
Figure 5: Exposure of the penile urethra. After a circumferential
incision, the penis is degloved along Buck’s fascia providing exposure
of the entire penile urethra.
5.3.4. Surgical Techniques
(1) End-to-End Urethroplasty. End-to-end urethroplasty or
excision and primary anastomosis (EPA) urethroplasty repre-
sents the surgical technique with the best long-term surgical
success, entailing a composite success rate of 93.8% [45, 46].
During this procedure, the diseased segment of the urethra
is excised and replaced by adjacent healthy urethral tissue,
without the need for grafts or flaps to bridge the gap (Figure 6)
[47].
Be that as it may, the indications for this surgical tech-
nique are restricted by the limited elasticity of the bulbar
urethra. In fact, only strictures up to 3.0 cm are to be treated
with end-to-end urethroplasty because the excision of longer
segments would hamper the creation of a well vascularized
and tension-free anastomosis, which is crucial for a successful
procedure. The intrinsic elasticity of the bulbar urethra is
estimated to be around 25% and, assuming an average bulbar
urethral length of 10 cm, a gap of up to 2.5 cm can be bridged.
Further length can be gained progressively by performing
additionalmaneuvers involving extensive proximal and distal
urethral mobilization, cleavage of the cavernous bodies,
supracrural rerouting, and inferior pubectomy [48]. If, even
after these length-gaining maneuvers, the gap between both
urethral ends remains too large, an augmentation using free
grafts or pedicled flaps will be inevitable [47].
Recommendations regarding urethroplasty of the bulbar
urethra are currently highly inconsistent and controversial
opinions are reported in literature: the International Consul-
tation on Urologic Diseases (ICUD) advises end-to-end ure-
throplasty as the technique of first choice in all isolated, short
(≤ 3.0 cm), bulbar urethral strictures while others may argue
that it is only indicated after bulbar trauma [48–50]. Apart
from that, end-to-end urethroplasty is also recommended
for posterior urethral strictures after pelvic fractures or after
prostate surgery or radiation [47, 51–53]. Herein, the scar
tissue is entirely excised and a bulbomembranous or bulbo-
prostatic anastomosis is created. A cystoscope or a curved
sound may be introduced in the suprapubic tract, down to
the proximal urethral portion, to guide the surgeon in his/her
surgical dissection and creation of the anastomosis [47, 51]. In
very unusual circumstances, a combined abdominoperineal
approach might be necessary [51]. In most of these patients
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with posterior urethral strictures, the elaborated anastomotic
repair technique defined by Webster et al. will suffice to
restore urethral continuity [48]. If this would not be the case,
substitution or staged urethroplasty remains a viable option.
End-to-end urethroplasty is contraindicated in most
penile urethral strictures, even in short ones, as EPA in this
segment may lead to penile shortening and chordee.
Nontransecting End-to-EndUrethroplasty. Traditionally, end-
to-end urethroplasty included full thickness transection of
the corpus spongiosum at the level of the stricture. How-
ever, as EPA only requires the excision of the narrowed
segment and the surrounding spongiofibrosis, a full thick-
ness transection of the corpus spongiosum, with the bul-
bar/urethral arteries within it, is usually unnecessary [47].
Against this background, Jordan et al. introduced the idea
of a “nontransecting” or “vessel-sparing” technique in 2007
[54] which was later slightly modified and popularized by
Andrich and Mundy (Figure 6) [55]. Many urethroplasty
centers have adopted this technique ever since and promising
results—in line with the success rates of the transecting
technique—have been reported [47, 56–59]. This nontran-
secting technique aims to reduce surgical trauma, especially
to the bulbar/urethral arteries embedded in the corpus
spongiosum. Preserving these arteries potentially reduces the
risk of postoperative erectile dysfunction or glans ischaemia.
Apart from that, vessel-sparing could also be beneficial for
subsequent urethral interventions requiring a well sustained
vascular milieu, such as free graft urethroplasty or the
implantation of an artificial urinary sphincter [47]. So far,
these potential benefits are only assumptions as there is only
one retrospective series suggesting a functional benefit for
nontransecting EPA over transecting EPA [59]. Prospective
randomized, controlled trials with validated questionnaires
will be needed to corroborate these suggestions.
This nontransecting variant of end-to-end urethroplasty
has also been introduced to treat posterior urethral strictures
[60, 61]. However, in these strictures, the bulbar arteries
and the cavernous vasculonervous bundles may already be
obliterated or damaged due to the pelvic fracture or previous
prostate treatments, abolishing the potential benefits of vessel
preservation. Furthermore, the anatomical proximity of the
membranous urethra to the urinary sphincter and the cav-
ernous vasculonervous bundles should be taken into account
and, if possible, a sphincter-sparing variant of nontransecting
end-to-end urethroplasty may be superior in terms of conti-
nence preservation [62].
For short (<1.0 cm) and not too narrow strictures,
a Heineke-Mikulicz urethroplasty can be performed with
excellent success rates (Figure 7) [63]. In this subtype of non-
transecting procedure, the stricture is longitudinally incised
and then closed transversely without excising the fibrotic
tissue. Some call this technique a stricturoplasty, rather than
a true urethroplasty.
(2) Free Graft Urethroplasty. From the moment a stricture
is no longer an indication for end-to-end urethroplasty,
a substitution urethroplasty is unavoidable [64]. Herein,
the use of a free graft represents the easiest and most
straightforward technique to treat strictures from the meatus
urethrae up to the posterior urethra. These free grafts can
be harvested from several sites such as the preputium, the
penile shaft, the oral cavity (buccal or lingual mucosa), the
tunica vaginalis, and exceptionally the bladder mucosa [64].
Various manners have been described to suture the harvested
graft onto or into the opened urethra (ventral onlay, dorsal
onlay, dorsolateral onlay, dorsal inlay, and combinations),
but tubularized grafts are to be avoided since these results
are far less favorable than the aforementioned substitution
techniques [64]. Furthermore, it is well known that free graft
procedures provide worse outcomes at the penile urethra
than at the bulbar urethra [64]. Most likely, this is the result
of a more limited amount of corpus spongiosum at the penile
site and its proximity to the urethral meatus and external,
colonized milieu.
Preputial Grafts versus Buccal Mucosa Grafts. Nowadays,
the trend is to use buccal mucosa grafts over preputial
grafts (Figure 8). However, this choice is mainly based upon
expert opinion as convincing evidence to support this is
currently lacking. Some retrospective reports have attempted
to investigate this issue but could not justify to choose one
over the other [65, 66]. Prospective, randomized, controlled
trials will be necessary to truly justify this trend and to bring
forward an evidence-based recommendation.
Despite its excellent success rates, buccal mucosa graft
urethroplasty also brings along some drawbacks. In contrast
to the use of preputial grafts, for instance, a second surgical
site—the oral cavity—needs to be disinfected and prepared
with sterile drapes, which lengthens the duration of the
procedure. Also, the surgeon taking the oral graft needs to
be familiar with the anatomy of the oral cavity. Furthermore,
it cannot be denied that the created defect in the buccal
mucosamay cause important pain and/or discomfort in these
patients, possibly resulting in a longer hospital stay. Persisting
oral symptomsmay involve pain, swelling, numbness, dimin-
ished taste, speech problems, and/or an impairment of the
mouth opening, smiling, or eating [67–69]. Nonetheless, the
use of buccal mucosa grafts has been a major asset in the
surgical repertoire to treat urethral stricture disease.
LingualMucosaGrafts. Lingual mucosa grafts can be utilized
as an alternative to buccal mucosa grafts (Figure 9). They are
harvested from the sublingual region, respecting the sublin-
gual nerve and the lingual papillae, which are important in
the perception of taste. The main advantage of this graft site
lies within its easy exposure, in contrast to an inner cheek.
However, the graft length that can be obtained is limited
to about 6.0-7.0 cm, depending on the size of the tongue.
A randomized, controlled trial performed by Lumen et al.
showed similar success and oral morbidity rates in buccal
and lingual mucosa graft use, but the type of oral discomfort
differed: lingual mucosa harvesting caused significantly more
dysgeusia and problems with eating and speaking whereas
buccal mucosa harvesting led to more oral tightness [70]. Be
that as it may, the use of lingual mucosa grafts has also been
an important asset in the armentarium of the reconstructive
urologist.




Figure 6: Nontransecting end-to-end urethroplasty. (a) = excision of the stricture and surrounding spongiofibrosis after dorsal, longitudinal
incision; (b) = ventral spatulation of the proximal and distal urethral end; (c) = transverse closure of the ventral urethral plate; (d, e) = transverse
closure of the dorsal urethra; (f) = spongioplasty.
To Close or Not to Close the Oral Graft Site. A recent
randomized, controlled trial by Soave et al. has shown that no
closure of the donor site is noninferior to closure of the donor
site regarding quality and intensity of oral pain (Figure 10)
[69].
Graft Placement. Originally, free graft urethroplasty always
involved a ventral placement of the graft on the longitudinally
opened urethral stricture: the so-called “ventral onlay” free
graft urethroplasty. Later, Barbagli et al. modified this tech-
nique and started placing grafts dorsally, against the cav-
ernous bodies: the so-called “dorsal onlay” free graft urethro-
plasty [71]. This technique seemed to have the advantage of
better graft fixation against its vascular bed and tended to
cause less sacculation than ventral onlay procedures. A recent
randomized, controlled trial, however, could not withhold
any differences between both types of graft placement in
the treatment of bulbar urethral strictures [72]. Hence, the
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Figure 7: Heineke-Mikulicz stricturoplasty. (a) = longitudinal incision over the stricture; (b) = transverse closure of the incision.
(a) (b)
Figure 8: Preputial graft versus buccal mucosa graft. (a) = preputial graft; (b) = buccal mucosa graft.
choice between a ventral and a dorsal onlay urethroplasty
is mainly left upon the surgeon’s discretion, but it remains
very case-specific and importantly driven by multiple patient
and stricture characteristics (e.g., previous urethral surgery,
stricture location, and quality of the local tissues). It is even
possible to combine both ventral and dorsal graft placement
in case of long-segment strictures or in case of very narrow
strictures, as described by Hudak et al. [73] and Palminteri et
al. [74].
Asopa has further modified this technique to a “dorsal
inlay” free graft urethroplasty in which the urethra must
not be dissected circumferentially to allow a dorsal onlay
of the free graft [75]. In fact, this technique involves a
ventral opening of the urethra followed by incising the dorsal
urethral plate from the inside of the lumen. This adjusted
approach has the advantage to be faster than a Barbagli
procedure and can efficiently be administered when the
surgeon intraoperatively finds that a ventral onlay procedure
will not be possible.The success rates of a Barbagli procedure
and an Asopa procedure are shown to be comparable [76].
It is a well-known fact that free graft urethroplasties at the
penile urethra entail lower success rates than more proximal
free graft procedures [64]. This observation may largely be
explained by the relative paucity of corpus spongiosum at
the more distal penile urethra. Hence, the graft almost fully
depends on the vascular supply of the subcutaneous tissue
in this region, which is strongly variable and much more
tenuous than at the bulbar site. Against this background, it is
assumed that dorsal graft placement is superior at the penile
urethra, because then the cavernous bodies can act as a good
vascular graft bed.
Later in the quest for minimally invasive urethroplasty,
Kulkarni et al. described a new technique: the one-sided
anterior urethroplasty with dorsolateral placement of the
graft [44]. As such, only one side of the anterior urethra is
dissected to allow graft augmentationwhile, on the other side,
the vascular, neural, and muscular structures of the urethra
are fully spared, which contributes to less tissue damage
during urethroplasty. This may be particularly interesting at
the penile urethra, where the vascular supply ismore tenuous
and rather vulnerable.
Failure after Free Graft Urethroplasty. The success of a free
graft urethroplasty importantly depends on the relationship
between the graft and its vascular bed.The graft has to be well
in contact with a rich vascular bed in absence of any infection
in order to survive. If one of these parameters is disturbed
in any way, the risk of graft necrosis, and thus failure, exists.
Even if none of these variables is disturbed, graft contracture
can occur and may lead to restenosis of the urethra [77].
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Figure 9: Lingual mucosa graft harvesting. (a) = right, sublingual graft site; (b) = submucosal fluid injection to allow hydrodissection.
Figure 10: Nonclosure of the graft site.The left, sublingual donor site
is left open after thorough hemostasis.
(3) Pedicled Flap Urethroplasty. Pedicled flaps carry their
own vascular supply in the pedicle and therefore can survive
independent of the surrounding tissues. The preputium
(Figure 11) and penile shaft skin (Figure 12) are both ideal
sites to mobilize a pedicled flap from to augment the penile
and/or the bulbar urethra up to the bulb of the corpus
spongiosum. In complicated cases, scrotal flaps can also be
administered, preferably after destruction of the hair follicles
[78], and, exceptionally, even intestinal flaps may be used for
extraordinary reconstructions [79].
Pedicled flap urethroplasty can be administered in basi-
cally every urethral stricture case, from the meatus up to
the posterior urethra, and is associated with excellent success
rates [64, 80–82]. Moreover, it is shown that tubularized flaps
perform as well as patch procedures, in contrast to free graft
procedures [80–82].
Undeniably, pedicled flap urethroplasty also brings along
several postoperative side-effects, such as sacculation and
intra-urethral hair growth, and should not be considered
a first-choice treatment for relatively simple cases. How-
ever, though technically challenging, every urethral surgeon
should master this variety of techniques, because, sooner or
later, this will be the only pertinent option left.
Figure 11: Duckett flap.Mobilization of a pedicledDuckett flap (inner
preputium).
(4) Multistage Urethroplasty. Given the outstanding success
rates of one-stage urethroplasty, the indications formultistage
procedures have diminished remarkably. Nowadays, staged
interventions are mostly reserved for redo cases in which
there’s a complete lack of healthy tissue and only very
precarious vascularization.
Almost every multistage urethroplasty technique is
derived from the original Johanson technique [83]. The
general principle of this technique is to first open the diseased
urethra longitudinally and then suture the created urethral
edges to the borders of penile/scrotal skin (depending on
stricture location). As such, the diseased urethra is left open
and a neo-meatus originates in a hypospadias position.This is
considered the first stage of a Johansonprocedure.The second
stage of Johanson’s procedure basically consists of retubu-
larizing this marsupialized urethra around a transurethral
catheter and is performed at earliest 3 months after the first
stage. In some patients, however, the urethral plate will be
of poor quality, even after several months. In these cases, it
might be necessary to incise this fibrotic or ischemic plate
dorsally and to augment the urethra with a free graft, placed
against the corporal bodies [84–88].
After Johanson, several surgeons—Turner-Warwick [89],
Gil-Vernet [90], and Blandy [91]—have further adapted the
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Figure 12: Orandi flap.Mobilization of a pedicled Orandi flap (ventral longitudinal island; penile shaft skin).
technique of staged urethroplasty, but the same idea is
basically always respected.
(5) Mesh Graft Urethroplasty or Multistage Oral Mucosa Graft
Urethroplasty. Mesh graft urethroplasty and multistage oral
mucosa graft urethroplasty both represent a variation of
multistage urethroplasty in which the disadvantages of tubu-
larizing hairy skin segments (stone formation; infection) are
avoided. With the mesh graft urethroplasty, a split thickness
skin graft is harvested using a dermatome and meshed,
and, with the multistage oral mucosa graft urethroplasty, a
piece of oral mucosa is harvested and prepared as described
above. The mesh graft or oral mucosa graft is then sutured
in between the created urethral edges (after opening of the
urethra) and the borders of the skin and, subsequently, during
the second stage, there is no need to tubularize hair bearing
skin, but only hairless graft material. These techniques are
mostly reserved for complex reconstructions andmesh grafts
are particularly interesting in cases with restricted graft/flap
options [92, 93].
(6) Definitive Perineostomy. Nowadays, multistage urethro-
plasty is almost exclusively preferred in rather complex
cases and in patients that have had numerous urethral
interventions already. Often, these patients are perfectly
happy to void without any problems after the first stage of
an intended multistage procedure and wish to retain the
created perineostomy without a second-stage procedure.This
definitive perineal urethrostomy represents a well-accepted
situation for many patients, especially multioperated and
older ones.
For the creation of a definitive perineostomy, the Johan-
son and Blandy techniques are most frequently used and
entail similar success rates [92]. With the Blandy technique, a
perineal inverted-U incision is performed and the tip of this
inverted-U flap is sutured against the deepest, most proximal
part of the opened urethra (Figure 13). An alternative tech-
nique is the use of a 7-shaped flap, as described by French
et al. [94]. In complex cases it might even be necessary to
administer free grafts or mesh grafts in the creation of a
perineostomy [95].
(7) Tissue-Engineering in Urethroplasty. Urethral reconstruc-
tion using matrix-bred tissue out of the patient’s own urothe-
lium or oral mucosa has recently been introduced as an
alternative approach which mainly addresses the limitations
inherent to the classic substitution urethroplasty. So far,
tissue engineering with urothelium has been described in
laboratory studies [96, 97] and, in 2018, Barbagli et al.
have reported a success rate of 86% after MukoCell graft
urethroplasty in a clinical study (median stricture length of
5.0 cm and median follow-up of 55 months) [98]. In their
technique, a 0.5 cm2 oral mucosa biopsy was harvested and
sent to the laboratory for tissue engineering. After 3 weeks,
the manufactured piece of tissue was sent back to the hospital
and administered during urethroplasty (ventral onlay, dorsal
onlay, dorsal inlay, and combinations).
Today, the largest limit of tissue engineering lies within
its cost, but, definitely, this technique involves several advan-
tages, especially when the classic substitution materials
become scarce or even totally absent. Furthermore, it reduces
the amount of donor tissue that is required for reconstruction
and could therefore potentially reduce the side-effects of the
graft site that are seen after a classic free graft urethroplasty
[98]. Nonetheless, to date, there is no data to support this
statement and future studies will be required to elucidate this
issue. Also, the same conditions as in a classic free graft ure-
throplasty (close, immobile contact with a well vascularized
graft bed in absence of infection) will be required to allow a
successful procedure.
(8) Combination of Techniques. In case of multiple urethral
strictures or very long, often complicated urethral strictures,
a combination of the aforementioned techniques might be
necessary to offer the patient a one-stage solution [99, 100].
In order to do so, a combined perineal and penile skin
incision might be necessary. The most popular combination
is probably represented by a free graft urethroplasty at
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Figure 13: Blandy perineostomy. (a) = inverted-U incision to create the Blandy flap; (b) = mobilized Blandy flap and exposure of the bulbar
urethra; (c) = opening of the strictured area until patent proximal urethra is reached; (d) = suturing the tip of the Blandy flap to the deepest point
of the opened urethra; (e) = further suturing the edges of the Blandy flap to the urethral edges; (f) = end-result of the Blandy perineostomy.
the bulbar urethra, combined with a pedicled flap at the
less vascularized penile urethra. However, basically every
combination is possible but should be administered with
common sense and respect to the urethral vascularization.
5.3.5. Choice of Surgical Technique. For a primary ure-
throplasty, the surgeon should always opt for the simplest
and most straightforward technique that yields the highest
success rates. Ideally, the chosen technique also represents
the treatment option that least compromises the therapeutic
armamentarium that might be needed in the future as there is
always a risk for urethroplasty failure requiring one or more
salvage treatments [101].
For isolated, short (≤3.0 cm), bulbar urethral strictures,
the authors follow the end-to-end urethroplasty recommen-
dation of the ICUD, although a lot of controversy exists as
mentioned above [46, 49, 50]. From the moment a stricture
can no longer be treated with anastomotic repair, substitution
urethroplasty will be required, in which a free graft urethro-
plasty represents the easiest and most evident technique to
treat stricture disease from the meatus up to the posterior
urethra [64]. Herein, penile urethral strictures are preferably
augmented dorsally because of the rich vascular bed that is
provided by the corporal bodies. In most cases, a free graft
procedurewill be favored over a pedicled flap procedure since
flap urethroplasties are technically more demanding and
interfere more with the external appearance of the genitals.
Furthermore, free graft urethroplasties importantly rely on
the quality of the urethral vascularization, which will be
progressively impoverished, surgery after surgery. Hence, it
makes sense to administer free grafts earlier in the treatment
cascade, thus fully utilizing its window of opportunity.
The more redo procedures a patient has undergone, the
harder it gets to choose between surgical approaches, as
the options become sparser and gradually less favorable. In
these cases, it is hard to stipulate general rules as these
treatment decisions are very case-specific and need to be
well deliberated. In long, complex andmultioperated urethral
strictures, a preputial or scrotal skin flap could remain a
viable option, at least if this tissue is still available. An
BioMed Research International 13
alternative is to perform a multistage urethroplasty or to
construct a definitive perineostomy, which is often well-
tolerated by patients with an elaborate history of urethral
stricture treatments.
It should be underlined that this decision-making process
may not be universal and that there is a lot of controversy
about treatment algorithms for urethral reconstruction, espe-
cially in the bulbar urethra [46, 49, 50]. However, no matter
which algorithm is used, it is of utmost importance that every
surgeon eager to perform a urethroplasty masters the variety
of techniques as described above, especially because an intra-
operative shift from one technique to another is sometimes
unavoidable. Hence, it must be stressed that urethroplasty
should only be performed in recognized referral centers with
sufficient volume.
5.3.6. Peculiar Urethral Stricture Conditions and Locations
(1) Posterior Urethral Strictures. These strictures are charac-
terized by the following:
(i) An anatomical proximity to the urethral sphincter
and possible extension deeper than the urogenital
diaphragm
(ii) A distraction defect between the prostatic apex and
the distal urethral portion
(iii) Concomitant hematoma formation, infection, and/or
previously failed urethral realignment procedures
(endoscopic or open) which might lead to extensive
stricture formation in the entire zone between both
disrupted urethral ends, which makes it hard to rec-
ognize the local anatomy. Furthermore, in strictures
related to a pelvic fracture, the displacement of bony
fragments might hamper the exposure, which further
complicates the surgical procedure
(iv) In traumatic strictures, the possibility of coexisting
damage to the penis, scrotum, and/or perineum,
which may heavily compromise the available surgical
options to restore the urethral continuity
The standard approach after trauma related urethral injuries
involves the immediate placement of a suprapubic catheter
[52] followed by a delayed urethroplasty, generally after 3
months, although, in reserved cases, a delay of 6 weeks may
be enough [102]. Placement of the suprapubic tube should
always be guided by imaging studies as the bladder may
have been displaced in all possible directions depending on
the impact of the trauma. Then, 3 months later, the ideal
moment for an end-to-end urethroplasty is reached because
the hematoma will have been resorbed and the distraction
defect between both urethral ends will beat its minimum.
(2) Meatal Strictures. Meatal strictures may be located only
at the meatus urethrae but can also expand in the navicular
fossa or the entire transglandular segment. In some cases, the
meatal stricture is part of an entire diseased anterior urethra.
A meatal stricture is often considered as a minor and
rather benign condition, although, in every case, the clinician
has to consider the possibility of underlying lichen sclerosus.
Furthermore, obtaining a perfectly functional and esthetic
result is harder than it may seem. Herein, the severe devia-
tion of the urinary stream represents the most bothersome
complication as it will obligate the patient to void in a sitting
position.
The true extent of a meatal stricture is often difficult to
estimate preoperatively. In pronounced strictures, a RUGwill
usually be impossible to perform and, during a VCUG, the
entire proximal urethral segment will dilate but will only
poorly reveal the true length of the stricture. In fact, the
most reliable lengthmeasurement takes place in the operating
theatre. Hence, the surgeon starting the meatoplasty should
always master a variety of techniques as every patient will
need an individualized surgical approach.
Several techniques have been described to reconstruct the
urethral meatus [103]. Many of these techniques, however,
do not involve a closure of the glans and thus leave behind
a hypospadias neo-meatus. From both a functional and an
esthetic point of view, one should always attempt to close the
glans and to restore the distal penile anatomy as meticulously
as possible. Penile skin flap meatoplasty represents one of the
suggested techniques but is nowadays gradually abandoned
as it often leads to a slightly hypospadias meatal position
afterwards. During this technique, a small pedicled penile
skin flap can easily be mobilized after a subglandular incision
to access the meatal urethra. An alternative approach is to
cleave the glans and to dorsally incise the urethral plate
into healthy, well vascularized tissue.Thereafter, an according
graft can be harvested and dorsally laid in, according to
Asopa [75], and the glans wings can be closed in two firm
layers to prevent fistulas and glandular dehiscence (Figure 14).
More recently, another alternative for meatal reconstruction
has been described by Nikolavsky and involves transmeatal
buccal mucosa graft repair of the meatus and navicular fossa
[104]. During this procedure a wedge of scar tissue is cut out
ventrally through themeatus and the tip of the buccal mucosa
graft is put into the apex of the created defect using a double-
armed suture following the inside-out principle. Thereafter,
both sutures are tied externally and the same principle is used
for the edges of the graft until adequate fixation is obtained.
The use of genital skin must be avoided in all patients
with a lichen sclerosus related stricture as it can lead to a
failed procedure [9]; in these cases, oral mucosa must be
administered [105].
(3) Lichen Sclerosus Related Strictures. Lichen sclerosus is
a chronic, inflammatory skin condition with a specific
predilection for the genital region. Furthermore, this disease
may importantly affect the penile as well as the bulbar urethra
[8, 9].These strictures are associated with higher failure rates
after urethroplasty than strictures of any other etiology and
require a specific therapeutic approach [9].
As mentioned above, it is generally accepted that lichen
sclerosus related strictures are not to be treated with skin as
substitution material, but with oral grafts [105]. Nonetheless,
it remains unclear whether oral mucosa grafts are actually
resistant to this disease or not.
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Figure 14: Asopa technique for meatal and navicular strictures. (a) = opening of the meatal stricture with a grooved director; (b) = incision of
the dorsal urethral plate; (c) = excision of fibrotic tissue; (d) = dorsal inlay of buccal mucosa graft.
Based on good dermatological results after high-dosed,
locally applied corticosteroids, its value has also been evalu-
ated for intra-urethral administration and has shown satisfy-
ing results in small patient series [106, 107]. It makes sense
that these substances would also be beneficial as an adjuvant
to urethroplasty, but so far there is no evidence to support this
statement.
(4) Urethral Strictures after Local Prostate Cancer Treatment.
All local treatment options for prostate cancer (radical
prostatectomy, external radiation therapy, brachytherapy, and
focal prostate cancer treatments like high intensity focused
ultrasound (HIFU) or cryotherapy) may contribute to sub-
sequent stricture formation, located between the bladder
neck and bulbar urethra [108]. These strictures are usually
characterized by intense fibrosis and poorly vascularized
surrounding tissues which may hamper a successful and
uncomplicated surgical procedure. In most of the cases,
an end-to-end urethroplasty is the technique of choice,
especially because these urethral strictures are usually rather
short [109–112]. The authors believe that if one of both
urethral ends is well vascularized, a decent to good success
rate may be expected [111]. Substitution urethroplasties have
also been described for this indication and seem to bring
along a successful surgical outcome [109, 112, 113]. However,
these numbers are based on highly selected patient series
and the true success of these procedures may have been
overestimated.
It must be acknowledged that, overall, these patients are
hard to treat and that urethroplasty in these cases holds
an important risk for failure. Furthermore, the presence of
a stricture may have concealed a problem of underlying
incontinence, which may suddenly appear after a successful
procedure in which the urethral patency has been restored.
Hence, all patients should be thoroughly informed preoper-
atively and well counseled about the potential consequences
of treating their stricture.
5.3.7. Impact of Urethroplasty on Sexual Life. In a literature
review incorporating 36 studies with a total of 2323 patients,
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persisting de novo erectile dysfunction has been described
in 1% of the patients after urethroplasty [114]. This number
strongly varied between different studies and ranged from
0% to 38%, which may be attributed to differences in patient
and stricture characteristics, types of repair, definitions of
erectile dysfunction, and methods of questioning. On the
other hand, a transitional decline in erectile function shortly
postoperative (6weeks) has been described with spontaneous
resolution after 6 to 12 months [115].
With the classic transecting end-to-end urethroplasty, the
erectile tissue is directly damaged during surgery and thus
one could expect that erectile function importantly decreases
after this procedure. This assumption has been illustrated by
a study of Ekerhult et al., although they could only withhold
a 5% incidence rate of de novo erectile dysfunction after
end-to-end procedures [116]. Herein, the question remains
whether nontransecting end-to-end urethroplasty is linked
to lower postoperative sexual dysfunction without impeding
the surgical success rates of urethroplasty by excision and
primary anastomosis [59]. As regards free graft urethro-
plasty with buccal mucosa, studies have shown that these
procedures do not impact the patients’ postoperative erectile
function [117, 118].
Ejaculatory function is often better after urethroplasty
than before, provided the use of a technique in which the
continuity of the bulbospongiosus muscle is actively restored
during the multilayered closure of the perineum [119, 120].
5.3.8. Postoperative Course. After urethral reconstruction, it
is important to provide urinary derivation as urine extravasa-
tion at the recently operated region might lead to important
complications, such as abscess formation and phlegmon.
When a free graft has been used, the authors routinely leave
a 20 Fr transurethral catheter in place to avoid prolapse of
the graft into the urethral lumen and to allow close contact
between the graft and its vascular bed. In other cases, urinary
derivation is assured through a 16 Fr transurethral catheter
or a suprapubic tube. Nonetheless, it should be underlined
that catheter use after urethral reconstruction is extremely
variable between different urethroplasty centers, without
clear data if one regimen is truly better than the other.
Most patients are discharged from the hospital on the sec-
ond or third postoperative day with the indwelling catheter
in place. At that moment, instructions for wound care are
provided, which are specifically important in patients with
a perineal wound. These wounds need to be kept dry and
clean. Therefore, the use of a hair dryer (3 to 4 times a
day) and repeated disinfection is advised, a method that
was copied from wound care principles after episiotomy in
females.
Routine perpetuation of the antibiotic treatment regimen
must be limited to those patients in which a preoperative
urinary tract infection has been established. In these cases,
appropriate antibiotics (according to the antibiogram) are
continued for a maximum of 5 days since any longer use will
only contribute to the problem of resistant microorganisms.
There is no clear evidence to support this advice in urethro-
plasty, although the authors base this recommendation upon
the general rules and principles of antibiotic therapy.
After 7 to 14 days, the first postoperative visit is scheduled
and involves the execution of aVCUG, after filling the bladder
with contrast medium through the indwelling catheter. Some
authors argue the value of a routine postoperative urethrog-
raphy as only few patients will show contrast extravasation
requiring a catheter replacement [121, 122]. However, these
authors routinely leave the catheter for 3 weeks instead of 1
or 2 weeks. It has been established that indwelling catheters
bring along important side-effects and complications and
thus it might certainly benefit the patient to remove the
catheter as early as possible [123]. Moreover, it has been
demonstrated in our department that catheter removal after
8 days is as safe as prolonged catheter dwell-time and
that extravasation at first VCUG has an important negative
prognostic value [124].
5.3.9. Follow-Upafter Urethroplasty. To date, the ideal follow-
up of patients after urethroplasty remains poorly defined. At
Ghent University Hospital, patients are scheduled to revisit
after 3months, after 12 months, and annually thereafter. Dur-
ing these visits, anamnesis, physical examination, uroflowme-
try, and Urethral Stricture Surgery Patient Reported Out-
come Measures (USS-PROM) questionnaires are routinely
administered [125, 126]. Additional urethrography and/or
cystoscopy are/is only performed in case of obstructive
voiding symptoms or a maximal flow rate of < 15 mL/s.
To date, there is no clear consensus about standard
administration of urethrography and/or urethroscopy during
follow-up. There is, however, a remarkable trend to use
patient-reported outcome measures (PROMs) after urethral
reconstruction. In 2011, Jackson et al. created and vali-
dated the USS-PROM, a questionnaire specifically made for
patients after urethroplasty [125]. Later, numerous validated
translations have been reported and implemented in routine
clinical practice [125–132].
The optimal follow-up schedule will need further elu-
cidation in the future. Presumably, this will not be a story
of “one-size-fits-all” as urethral stricture disease entails a
very heterogeneous patient cohort which certainly demands
patient-adapted follow-up strategies.
6. Conclusion
Male urethral stricture disease embodies a very hetero-
geneous condition in which thorough knowledge about
anatomy, etiology, symptoms, diagnosis, and treatment
aspects is crucial in optimizing care of these patients. Future
prospective research will be warranted to gain further evi-




DVIU: Direct vision internal urethrotomy
EPA: Excision and primary anastomosis
HIFU: High intensity focused ultrasound
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ICUD: International Consultation on Urologic
Diseases
MMC: Mitomycin C
MRI: Magnetic resonance imaging
Qmax: Maximal urinary flow rate
RR: Relative risk
RUG: Retrograde urethrography
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